In 2023, the composite success rate for clinical development in biopharma hit its highest level since 2018 thanks to the adoption of novel trial designs, predictive biomarkers, and digital methodologies, according to IQVIA. But waning R&D productivity is a significant industry concern. A substantial number of life science executives believe their organizations need to rethink…
2024: AI and scientists take turns at the wheel of drug discovery
In drug discovery, interest in harnessing the power of AI ramped up significantly with breakthroughs like AlphaFold, where AI predicted protein structures with astounding accuracy. AI’s initial focus was analyzing existing data, with machine learning systems excelling at tasks like predicting new drug interactions, molecular behaviors, and even biological pathways, based on troves of experimental…